000 04129nam a22003975i 4500
001 100755
003 ESmaUEC
005 20230102113010.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 180920s2018 gw | s |||| 0|eng d
020 _a9783319974217
_9
024 7 _a10.1007/978-3-319-97421-7
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
050 4 _aQP114.C44 2018 EB
245 1 0 _aCardiac Extracellular Matrix :
_bFundamental Science to Clinical Applications
_cedited by Eric G. Schmuck, Peiman Hematti, Amish N. Raval.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (XII, 246 páginas 35 ilustraciones,33 ilustraciones a color)
336 _aTexto
_btxt
_2rdacontent
347 _atext file
_bPDF
_2
490 0 _aAdvances in Experimental Medicine and Biology
_x0065-2598
_v1098
505 0 _aPreface -- Biomechanical Properties and Mechanobiology of Cardiac ECM -- Imaging the Cardiac Extracellular Matrix -- Animal Models and Cardiac Extracellular Matrix Research -- Applications of Cardiac Extracellular Ma-trix in Tissue Engineering and Regenera-tive Medicine -- Whole Cardiac Tissue Bioscaffolds -- Natural Sources of Extracellular Matrix for Cardiac Repair -- Cardiac Extracellular Matrix Modification as a Therapeutic Approach -- Extracellular Matrix for Myocardial Repair -- Role of Extracellular Matrix in Cardiac Cellular Therapies -- Regulation of Regenerative Medicine Products -- Clinical Trial Design for Investigational Cardio-Regenerative Therapy -- Regenerative Medicine Venturing at the University-Industry Boundary: Implications for Institutions, Entrepreneurs, and Industry -- Index.
520 3 _aThis book on cardiac extracellular matrix (ECM) features three sections, Fundamental Science, Pre-Clinical and Translational Science, and Clinical Applications. In the Fundamental Science section, we will cover the spectrum of basic ECM science from ECM's role in development, biomechanical properties, cardiac ECM influence of cardiomyocyte biology, pathophysiology of ECM in heart disease, and ECM in tissue engineering. Section two, Preclinical and Translational Science, will discuss cardiac ECM technologies in the clinical pipeline including approaches to ECM as a therapeutic, animal models of cardiac research, tracking and imaging methods of cardiac ECM, and cGMP manufacturing and regulatory considerations for ECM based therapeutics. Finally, the third section, Clinical Applications, will highlight the clinical experience around cardiac ECM including therapeutic strategies targeting scar tissue in the heart, Clinical trial design and regulatory considerations, current human clinical trials in cardiovascular medicine and the role of pharmaceutical and biotech companies in the commercialization of ECM technologies for cardiovascular indications. This book provides a comprehensive review for basic and translational researchers as well as clinical practitioners and those involved in commercialization, regulatory and entrepreneurial activities.
650 7 _aCorazón
_xEnfermedades
_2embne
_9169667
650 7 _aCitología
_2embne
_9139477
700 1 _aSchmuck, Eric G.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aHematti, Peiman.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_0http://id.loc.gov/authorities/names/nb2013007587
_1http://viaf.org/viaf/295211428
_984638
700 1 _aRaval, Amish N.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_0http://id.loc.gov/authorities/names/no2005046756
_1http://viaf.org/viaf/148105729
_9106996
776 0 8 _iEdición impresa:
_z9783319974200
776 0 8 _iEdición impresa:
_z9783319974224
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-97421-7
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490 0 _aBiomedical and Life Sciences (Springer-11642)
942 _2lcc
998 _aSI
_a_alco
_a_vill
_b04/2019
_cm
_dz
_ek
_feng
_ggw
_h0
999 _c100755
_d100755
_x1